4 completed, 3 unknown, 2 withdrawn, 1 recruiting. 10 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 4, Unknown 3, Withdrawn 2, Recruiting 1 |
Follow Eylea: new trials by email Literature Review of Eylea trials Research Report on Eylea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients Intravitreal injection of Faricimab or Aflibercept 2 mg - Renal Function Disorder, Diabetic Macular Edema (DME) | Not applicable | Recruiting | University Hospital, Alexandroupolis | 60 | 2025-03-10 | 2025-04-24 |
| Ozurdex in Suboptimal Diabetic Macular Edema Patients Intravitreal Implant in Applicator, Eylea - Diabetic Macular Edema | Not applicable | Unknown | Uptown Eye Specialists | 200 | 2021-05-25 | 2021-05-12 |
| Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT) - Polypoidal Choroidal Vasculopathy | Not applicable | Completed | Singapore National Eye Centre | 60 | 2021-02-01 | 2025-11-18 |
| Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept Aflibercept Injection (2 mg/0.05 ml), Defer treatment - Polypoidal Choroidal Vasculopathy | Not applicable | Unknown | Chiang Mai University | 80 | 2020-11-01 | 2021-01-15 |
| BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration intravitreal injection - Macula Lutea Degeneration | Not applicable | Unknown | Benha University | 40 | 2020-08-05 | 2021-05-12 |
| Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD Aflibercept, Triamcinolone Acetonide, Verteporfin - Neovascular Age-related Macular Degeneration | Not applicable | Withdrawn | Duke University | 2016-01-01 | 2017-07-26 | |
| A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. Ranibizumab, Aflibercept - Age Related Macular Degeneration | Not applicable | Completed | King's College Hospital NHS Trust | 59 | 2014-06-01 | 2021-04-30 |
| Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy aflibercept - Pattern Dystrophy of Macula | Not applicable | Withdrawn | Manhattan Eye, Ear & Throat Hospital | 2013-10-01 | 2014-12-31 | |
| Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma Aflibercept - Neovascular Glaucoma | Not applicable | Completed | University of Colorado, Denver | 7 | 2013-01-01 | 2022-03-18 |
| Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival Xylocaine 2% Injectable Anesthetic, Proparacaine Hydrochloride 0.5% Drop, Tetravisc 0.5% Gel - Age-related Macular Degeneration, Central Retinal Vein Occlusion | Not applicable | Completed | Retina Vitreous Associates of Florida | 57 | 2012-07-01 | 2014-04-21 |
Macular Degeneration (4) · Polypoidal Choroidal Vasculopathy (2) · Diabetes Mellitus (1) · Glaucoma, Neovascular (1) · Pain (1) · Retinal Vein Occlusion (1)
Benha University (1) · Chiang Mai University (1) · Duke University (1) · King's College Hospital NHS Trust (1) · Manhattan Eye, Ear & Throat Hospital (1) · Retina Vitreous Associates of Florida (1) · Singapore National Eye Centre (1) · University Hospital, Alexandroupolis (1) · University of Colorado, Denver (1) · Uptown Eye Specialists (1)
United States (4) · Greece (1) · Singapore (1) · Thailand (1) · United Arab Emirates (1) · United Kingdom (1)
Gemmy Cheung Chui Ming (1) · Lawrence A. Yannuzzi, M.D. (1) · Malik Y Kahook, MD (1) · Priyatham Mettu, MD (1) · Steven M Cohen, MD (1) · Tarek Elhamaky, MD (1) · Timothy L Jackson, PhD,FRCOphth (1)